GENEVA, May 15 -- VIONELIX PHARMACEUTICALS, INC. (555 Fayetteville StRaleigh, North Carolina 27601) filed a patent application (PCT/US2024/054396) for "MUTATION-RESISTANT ANTI-VIRAL COMPOSITIONS" on Nov 04, 2024. With publication no. WO/2025/097126, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AMIRAK, Emre (c/o Vionelix Pharmaceuticals, Inc.555 Fayetteville StRaleigh, North Carolina 27601)

Abstract: A therapeutic anti-viral strategy uses a plurality of oligonucleotides directed against multiple target sequences with...